How does adenosine control neuronal dysfunction and neurodegeneration?
RA Cunha - Journal of neurochemistry, 2016 - Wiley Online Library
The adenosine modulation system mostly operates through inhibitory A1 (A1R) and
facilitatory A2A receptors (A2AR) in the brain. The activity‐dependent release of adenosine …
facilitatory A2A receptors (A2AR) in the brain. The activity‐dependent release of adenosine …
Physiology and pathophysiology of purinergic neurotransmission
G Burnstock - Physiological reviews, 2007 - journals.physiology.org
This review is focused on purinergic neurotransmission, ie, ATP released from nerves as a
transmitter or cotransmitter to act as an extracellular signaling molecule on both pre-and …
transmitter or cotransmitter to act as an extracellular signaling molecule on both pre-and …
[HTML][HTML] Astrocytes are endogenous regulators of basal transmission at central synapses
A Panatier, J Vallée, M Haber, KK Murai, JC Lacaille… - Cell, 2011 - cell.com
Basal synaptic transmission involves the release of neurotransmitters at individual synapses
in response to a single action potential. Recent discoveries show that astrocytes modulate …
in response to a single action potential. Recent discoveries show that astrocytes modulate …
Purinergic signalling in neuron–glia interactions
RD Fields, G Burnstock - Nature Reviews Neuroscience, 2006 - nature.com
Activity-dependent release of ATP from synapses, axons and glia activates purinergic
membrane receptors that modulate intracellular calcium and cyclic AMP. This enables glia to …
membrane receptors that modulate intracellular calcium and cyclic AMP. This enables glia to …
[HTML][HTML] Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the
central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory …
central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory …
Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration
J Stockwell, E Jakova, FS Cayabyab - Molecules, 2017 - mdpi.com
The inhibitory adenosine A1 receptor (A1R) and excitatory A2A receptor (A2AR) are
predominantly expressed in the brain. Whereas the A2AR has been implicated in normal …
predominantly expressed in the brain. Whereas the A2AR has been implicated in normal …
Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
RA Cunha - Purinergic signalling, 2005 - Springer
Adenosine is a neuromodulator that operates via the most abundant inhibitory adenosine A
1 receptors (A 1 Rs) and the less abundant, but widespread, facilitatory A 2A Rs. It is …
1 receptors (A 1 Rs) and the less abundant, but widespread, facilitatory A 2A Rs. It is …
Purinergic signalling in brain ischemia
Ischemia is a multifactorial pathology characterized by different events evolving in the time.
After ischemia a primary damage due to the early massive increase of extracellular …
After ischemia a primary damage due to the early massive increase of extracellular …
Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline
RA Cunha, PM Agostinho - Journal of Alzheimer's Disease, 2010 - content.iospress.com
Caffeine, the most widely consumed psychoactive drug, enhances attention/vigilance,
stabilizes mood, and might also independently enhance cognitive performance. Notably …
stabilizes mood, and might also independently enhance cognitive performance. Notably …
Purinergic signaling orchestrating neuron-glia communication
P Agostinho, D Madeira, L Dias, AP Simões… - Pharmacological …, 2020 - Elsevier
This review discusses the evidence supporting a role for ATP signaling (operated by P 2 X
and P 2 Y receptors) and adenosine signaling (mainly operated by A 1 and A 2A receptors) …
and P 2 Y receptors) and adenosine signaling (mainly operated by A 1 and A 2A receptors) …